I was wondering if anyone could give me some info about Deloitte Strat HCLS: type of work they do i.e. if they do actual strat work, how they compare to MBB, exit options after say 2-3 years with them at SC level and any other useful info.Cheers

To be frank, Deloitte Healthcare and Life Sciences (HCLS) in London has a very poor reputation. Compared to other groups, it's not a popular place to work.This is mainly due to an extended period in which it has run by a cabal of highly incompetent and bullying characters. The consequent departure of good consultants and crushing of potentially good future consultants hasn't helped with either the selling or delivery of good work.Faced with a choice of which group to align themselves to, I do not know of anybody at Deloitte in the UK who voluntarily chooses Healthcare. Therefore, you tend to get an influx of last-chancers and no-hopers.In terms of the work, the NHS is (not entirely surprisingly) the biggest client. Projects tend to be focus on supporting elements of public sector transformation, such as running the PMO, conducting research and developing business cases, or reviewing performance of existing transformation programmes. So it is less hands-on than "pure operational" consulting but is by no means "corporate strategy". That said, this work is also typical of equivalent groups at MBB and Big 4. Healthcare is just not as high-strategy a market and group as Consumer Products, for example.Not many SCs stick around 2-3 years, but if you stay that long you'd likely transfer out into a different part of DC or move to a similar position or group in another of the Big 4.

Thanks for this information. Looking at the vault rankings, European Pharma/HC consulting, Deloitte is 7th (behind MBBB, ZS and Monitor). In the US they are 6th (down from 4th in 2008). Taking this into account I am a bit skeptical if they can actually be as bad as you say they are. How would they compare to the other big 4 or smaller boutique players?In terms of the work as far as I know they do strat stuff for the NHS (HC part), as you mention, but also for big pharma/biotech (LS part). You have any idea how/if the work varies between the two parts?Finally is it possible to make a shift into MBB HC practice after a year or two or is Deloitte generally looked down upon by MBB? How about exit into industry?Cheers

So your point is that you've taken Vault rankings for gospel and are seeking information to reinforce that belief. Wow, with a talent like that, I wouldn't worry about MBB or even DC. Try EY BAS.

Anja, if you really believe that work constitutes "strategy consulting" then you are drunk on the Koolaid. Like the previous poster said, look at BAS - they're more your style.

To the above two posters: No you morons I have not taken the vault rankings for gospel and I am not saying that Deloitte HCLS does purely strat work - the point if the thread is to collect info. However flawed the rankings may be and no mater what your idiotic opinion of them is they are an indicator, possibly a more relevant indicator when compared to the questionable "info" offered by some anonymous joe blow on this board. If you wanna participate in this thread please do so if you have to offer useful info. If not hold the negative wise-ass comments and go crawl back under your rock.

It does not matter where you are. Is are you happy where you are that matters...so all the crap about MBB ZBB whatever is not important you will still be another statistic working to make a shareholder richer and you think that is prestige....haha sorry for you mate all of you that scream MBB or ACN or ZBB

Deloitte HCLS have a very similar market positioning to the other Big4 and will typically be up against one or two of them where there are head-to-head pitches.It is fairly rare to be up against boutiques (DC go for projects involving larger resource commitments). It is also rare to be up against MBBB (DC play to strengths involving the integrated nature of the technology consulting and corp. fin. practices and go in at lower price points).That said, MBBB are increasingly shifting toward operational consulting and pushing into an overlapping space. For example, I would not be surprised, given McKinsey's near-stanglehold on the Department of Health, if they make a more aggressive push to get into the NHS.MBBB wouldn't typically hire ex-DC for reasons of brand and prestige. I think that's fair to say, given how many DC consultants (many very good) try applying each year. However, as MBBB push into the operational space, that may change. As described above, if you positioned yourself at DC as a relationship manager to the the NHS then McK BTO might be interested in you. Of course, you're unlikely to get to that level in DC HCLS without joining the cabal, which will leave you with a vested financial interest not to move.